Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Vivos Therapeutics, Inc. (VVOS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/16/2023 |
8-K
| Quarterly results |
| 06/08/2023 |
8-K
| Quarterly results |
| 05/16/2022 |
8-K
| Quarterly results |
| 03/31/2022 |
8-K
| Quarterly results|
Docs:
|
"VIVOS THERAPEUTICS INC. Consolidated Balance Sheets December 31, 2021 and 2020 Unaudited 2021 2020 ASSETS Current assets Cash and cash equivalents $ 24,030 $ 18,206 Accounts receivable, net of allowance of $180 and $508, respectively 1,203 1,431 Current portion of note receivable from related party - 84 Tenant improvement allowance receivable 516 - Prepaid expenses and other current assets 1,575 673 Total current assets 27,324 20,394 Long-term assets Goodwill 2,843 2,671 Property and equipment, net 2,825 872 Note receivable from related party, net of current portion - 811 Intangible assets, net 341 270 Deposits and other 356 309 Total assets $ 33,689 $ 25,327 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities Accounts payable $ 920 $ 781 Payable to related party for redemption of Ser..." |
|
| 11/15/2021 |
8-K
| Quarterly results |
| 08/12/2021 |
8-K
| Quarterly results |
| 05/17/2021 |
8-K
| Quarterly results |
| 03/25/2021 |
8-K
| Quarterly results |
|
|